These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 24196768

  • 1. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
    Mansini AP, Rubio PL, Rossi JG, Gallego MS, Medina A, Zubizarreta PA, Felice MS, Alonso CN.
    Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
    [Abstract] [Full Text] [Related]

  • 2. The impact of trisomy 21 on early human hematopoiesis.
    Roy A, Cowan G, Vyas P, Roberts I.
    Cell Cycle; 2013 Feb 15; 12(4):533-4. PubMed ID: 23343767
    [No Abstract] [Full Text] [Related]

  • 3. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
    Anoop P, Atra A.
    J Pediatr Hematol Oncol; 2012 Nov 15; 34(8):640. PubMed ID: 23007419
    [Abstract] [Full Text] [Related]

  • 4. "TAM"ing of the shrew-challenges in the diagnosis of Neonatal leukemia with Down's syndrome -A case report with literature review.
    Manohar S, Jayakumar N.
    Indian J Pathol Microbiol; 2022 Nov 15; 65(3):699-701. PubMed ID: 35900507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
    Watanabe K.
    Pediatr Int; 2019 Mar 15; 61(3):222-229. PubMed ID: 30593694
    [Abstract] [Full Text] [Related]

  • 8. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
    Toki T, Kanezaki R, Kobayashi E, Kaneko H, Suzuki M, Wang R, Terui K, Kanegane H, Maeda M, Endo M, Mizuochi T, Adachi S, Hayashi Y, Yamamoto M, Shimizu R, Ito E.
    Blood; 2013 Apr 18; 121(16):3181-4. PubMed ID: 23440243
    [Abstract] [Full Text] [Related]

  • 9. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.
    Leuk Res; 2005 Nov 18; 29(11):1353-6. PubMed ID: 15916804
    [Abstract] [Full Text] [Related]

  • 10. Transient abnormal myelopoiesis in non-Down syndrome neonate.
    Ohkawa T, Miyamoto S, Sugie M, Tomizawa D, Imai K, Nagasawa M, Morio T, Mizutani S, Takagi M.
    Pediatr Int; 2015 Nov 18; 57(1):e14-7. PubMed ID: 25711269
    [Abstract] [Full Text] [Related]

  • 11. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
    Nakashima MO, Shetty S, Chicka M, Flagg A, Eng C, Cotta CV.
    Pediatr Blood Cancer; 2015 Feb 18; 62(2):353-355. PubMed ID: 25175265
    [Abstract] [Full Text] [Related]

  • 12. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.
    Sah RR, Ray S, Bhatia P, Dhir SK, Totadri S, Kumar N, Kumar P.
    J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e292-e295. PubMed ID: 31876781
    [Abstract] [Full Text] [Related]

  • 13. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A, Roberts I, Vyas P.
    Semin Fetal Neonatal Med; 2012 Aug 01; 17(4):196-201. PubMed ID: 22421527
    [Abstract] [Full Text] [Related]

  • 14. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
    Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Mann G, Binder V, Borkhardt A, Kempski H, Trka J, Bielorei B, Avigad S, Stark B, Smith O, Dastugue N, Bourquin JP, Tal NB, Green AR, Izraeli S.
    Lancet; 2008 Oct 25; 372(9648):1484-92. PubMed ID: 18805579
    [Abstract] [Full Text] [Related]

  • 15. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E, Rentas S, Wertheim G, Cao K, Surrey LF, Lin F, Zhao X, Obstfeld A, Aplenc R, Luo M, Li MM.
    Cold Spring Harb Mol Case Stud; 2021 Apr 25; 7(2):. PubMed ID: 33832921
    [Abstract] [Full Text] [Related]

  • 16. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A, Peeters M, Poon A.
    Pediatr Hematol Oncol; 1987 Apr 25; 4(3):211-30. PubMed ID: 2978961
    [Abstract] [Full Text] [Related]

  • 17. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
    Lum SH, Choong SS, Krishnan S, Mohamed Z, Ariffin H.
    Singapore Med J; 2016 Jun 25; 57(6):320-4. PubMed ID: 27353457
    [Abstract] [Full Text] [Related]

  • 18. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder.
    Groet J, McElwaine S, Spinelli M, Rinaldi A, Burtscher I, Mulligan C, Mensah A, Cavani S, Dagna-Bricarelli F, Basso G, Cotter FE, Nizetic D.
    Lancet; 2003 May 10; 361(9369):1617-20. PubMed ID: 12747884
    [Abstract] [Full Text] [Related]

  • 19. A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.
    Kim IS, Park ES, Lim JY, Ki CS, Chi HS.
    J Korean Med Sci; 2008 Dec 10; 23(6):1105-8. PubMed ID: 19119459
    [Abstract] [Full Text] [Related]

  • 20. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D, Reinhardt K, Neuhoff C, Sander A, Klusmann JH, Pekrun A, Sauerbrey A, von Stackelberg A, Rössig C, Creutzig U, Kolenova A.
    Klin Padiatr; 2012 Apr 10; 224(3):153-5. PubMed ID: 22513796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.